CD4 and neoplasm: In the present study, as part of this investigation, multiplex IHC analysis was performed on a small number of patients whose tumours were biopsied, and an increase in CD4+ and CD8+ T cells was observed within the tumour tissues at 3 or 5 weeks after GX-I7 administration.